Merit Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Merit Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,780	Closed	-$22K	–	722
2022 Q3	$22K	Hold	13,780	–	–	﹤0.01%	556
2022 Q2	$28K	Sell	13,780 -3,900	-22%	-$6.74K	﹤0.01%	555
2022 Q1	$41K	Hold	17,680	–	–	﹤0.01%	376
2021 Q4	$82K	Sell	17,680 -4,000	-18%	-$24.8K	0.01%	272
2021 Q3	$165K	Hold	21,680	–	–	0.02%	258
2021 Q2	$210K	Buy	21,680 +1,000	+5%	+$7.96K	0.02%	253
2021 Q1	$171K	Buy	20,680 +1,000	+5%	+$10.6K	0.02%	227
2020 Q4	$134K	Hold	19,680	–	–	0.01%	207
2020 Q3	$219K	Buy	19,680 +5,680	+41%	+$52K	0.02%	200
2020 Q2	$88K	Buy	+14,000	New	+$53.6K	0.01%	210

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Merit Financial Group's SRNE Position: Q4 2022 in Review

Merit Financial Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 13,780 shares — an estimated $22K sold.

Merit Financial Group first reported a position in SRNE in Q2 2020 and held it in 10 quarters. The position peaked at $219K in Q3 2020. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Merit Financial Group reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Merit Financial Group sold 13,780 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $22K.
Merit Financial Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 10 quarters.
Merit Financial Group's Sorrento Therapeutics, Inc. position peaked at $219K in Q3 2020.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Merit Financial Group's 13F filing for Q4 2022, filed 13 Jan 2023.